Tempo Scan Pacific Tbk
PT Tempo Scan Pacific Tbk engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally. The company operates through Pharmaceuticals, Consumer Products and Cosmetics, and Distribution Services segments. It is involved in the pharmaceutical and medical devices trading; manufacture of soaps, herbal products, powder milk, food and… Read more
Tempo Scan Pacific Tbk (TSPC) - Net Assets
Latest net assets as of June 2025: Rp9.44 Trillion IDR
Based on the latest financial reports, Tempo Scan Pacific Tbk (TSPC) has net assets worth Rp9.44 Trillion IDR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp12.75 Trillion) and total liabilities (Rp3.31 Trillion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rp9.44 Trillion |
| % of Total Assets | 74.05% |
| Annual Growth Rate | 9.2% |
| 5-Year Change | 43.49% |
| 10-Year Change | 110.99% |
| Growth Volatility | 3.76 |
Tempo Scan Pacific Tbk - Net Assets Trend (2000–2024)
This chart illustrates how Tempo Scan Pacific Tbk's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Tempo Scan Pacific Tbk (2000–2024)
The table below shows the annual net assets of Tempo Scan Pacific Tbk from 2000 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Rp9.15 Trillion | +13.45% |
| 2023-12-31 | Rp8.07 Trillion | +6.82% |
| 2022-12-31 | Rp7.55 Trillion | +9.82% |
| 2021-12-31 | Rp6.88 Trillion | +7.81% |
| 2020-12-31 | Rp6.38 Trillion | +10.12% |
| 2019-12-31 | Rp5.79 Trillion | +6.59% |
| 2018-12-31 | Rp5.43 Trillion | +6.90% |
| 2017-12-31 | Rp5.08 Trillion | +9.64% |
| 2016-12-31 | Rp4.64 Trillion | +6.87% |
| 2015-12-31 | Rp4.34 Trillion | +4.96% |
| 2014-12-31 | Rp4.13 Trillion | +6.97% |
| 2013-12-31 | Rp3.86 Trillion | +15.20% |
| 2012-12-31 | Rp3.35 Trillion | +10.09% |
| 2011-12-31 | Rp3.05 Trillion | +15.17% |
| 2010-12-31 | Rp2.64 Trillion | +8.24% |
| 2009-12-31 | Rp2.44 Trillion | +5.73% |
| 2008-12-31 | Rp2.31 Trillion | +4.35% |
| 2007-12-31 | Rp2.21 Trillion | +9.00% |
| 2006-12-31 | Rp2.03 Trillion | +8.47% |
| 2005-12-31 | Rp1.87 Trillion | +4.12% |
| 2004-12-31 | Rp1.80 Trillion | +9.71% |
| 2003-12-31 | Rp1.64 Trillion | +9.54% |
| 2002-12-31 | Rp1.50 Trillion | +12.24% |
| 2001-12-31 | Rp1.33 Trillion | +20.44% |
| 2000-12-31 | Rp1.11 Trillion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Tempo Scan Pacific Tbk's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1282.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rp8.03 Trillion | 92.38% |
| Common Stock | Rp225.49 Billion | 2.59% |
| Other Components | Rp436.68 Billion | 5.03% |
| Total Equity | Rp8.69 Trillion | 100.00% |
Tempo Scan Pacific Tbk Competitors by Market Cap
The table below lists competitors of Tempo Scan Pacific Tbk ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Amosense Co. Ltd.
KQ:357580
|
$70.41 Million |
|
Forrester Research Inc
NASDAQ:FORR
|
$70.46 Million |
|
Digital Daesung Co. Ltd
KQ:068930
|
$70.47 Million |
|
ESGL Holdings Limited Ordinary Shares
NASDAQ:ESGL
|
$70.49 Million |
|
Bien Sparebank ASA
OL:BIEN
|
$70.29 Million |
|
Eucatex S.A. Indústria e Comércio
SA:EUCA3
|
$70.28 Million |
|
Petrovietnam Low Pressure Gas Distribution JSC
VN:PGD
|
$70.26 Million |
|
Sound Financial Bancorp Inc
NASDAQ:SFBC
|
$70.25 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Tempo Scan Pacific Tbk's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 7,697,948,551,517 to 8,689,772,801,000, a change of 991,824,249,483 (12.9%).
- Net income of 1,447,724,541,000 contributed positively to equity growth.
- Dividend payments of 397,056,294,000 reduced retained earnings.
- Other comprehensive income decreased equity by 87,451,042,697.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rp1.45 Trillion | +16.66% |
| Dividends Paid | Rp397.06 Billion | -4.57% |
| Other Comprehensive Income | Rp-87.45 Billion | -1.01% |
| Other Changes | Rp28.61 Billion | +0.33% |
| Total Change | Rp- | 12.88% |
Book Value vs Market Value Analysis
This analysis compares Tempo Scan Pacific Tbk's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.36x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 6.57x to 1.36x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-12-31 | Rp398.50 | Rp2620.00 | x |
| 2006-12-31 | Rp431.65 | Rp2620.00 | x |
| 2007-12-31 | Rp470.14 | Rp2620.00 | x |
| 2008-12-31 | Rp496.82 | Rp2620.00 | x |
| 2009-12-31 | Rp535.30 | Rp2620.00 | x |
| 2010-12-31 | Rp578.69 | Rp2620.00 | x |
| 2011-12-31 | Rp668.15 | Rp2620.00 | x |
| 2012-12-31 | Rp738.28 | Rp2620.00 | x |
| 2013-12-31 | Rp849.38 | Rp2620.00 | x |
| 2014-12-31 | Rp908.17 | Rp2620.00 | x |
| 2015-12-31 | Rp953.03 | Rp2620.00 | x |
| 2016-12-31 | Rp1018.27 | Rp2620.00 | x |
| 2017-12-31 | Rp1065.96 | Rp2620.00 | x |
| 2018-12-31 | Rp1141.53 | Rp2620.00 | x |
| 2019-12-31 | Rp1219.23 | Rp2620.00 | x |
| 2020-12-31 | Rp1345.82 | Rp2620.00 | x |
| 2021-12-31 | Rp1450.72 | Rp2620.00 | x |
| 2022-12-31 | Rp1599.87 | Rp2620.00 | x |
| 2023-12-31 | Rp1706.91 | Rp2620.00 | x |
| 2024-12-31 | Rp1926.76 | Rp2620.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Tempo Scan Pacific Tbk utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 16.66%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 10.60%
- • Asset Turnover: 1.09x
- • Equity Multiplier: 1.44x
- Recent ROE (16.66%) is above the historical average (16.28%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | 33.02% | 23.96% | 1.02x | 1.36x | Rp242.46 Billion |
| 2001 | 24.94% | 17.75% | 1.07x | 1.31x | Rp189.87 Billion |
| 2002 | 22.22% | 16.14% | 1.08x | 1.28x | Rp173.95 Billion |
| 2003 | 20.72% | 15.19% | 1.09x | 1.25x | Rp166.94 Billion |
| 2004 | 18.95% | 13.68% | 1.11x | 1.25x | Rp153.24 Billion |
| 2005 | 16.55% | 11.88% | 1.06x | 1.31x | Rp117.50 Billion |
| 2006 | 14.03% | 9.99% | 1.10x | 1.28x | Rp78.34 Billion |
| 2007 | 13.16% | 8.91% | 1.13x | 1.31x | Rp66.79 Billion |
| 2008 | 14.34% | 8.82% | 1.22x | 1.33x | Rp97.08 Billion |
| 2009 | 14.94% | 8.00% | 1.38x | 1.35x | Rp119.08 Billion |
| 2010 | 18.77% | 9.52% | 1.43x | 1.38x | Rp228.48 Billion |
| 2011 | 18.83% | 9.79% | 1.36x | 1.41x | Rp265.38 Billion |
| 2012 | 18.90% | 9.47% | 1.43x | 1.39x | Rp295.73 Billion |
| 2013 | 16.60% | 9.26% | 1.27x | 1.41x | Rp252.40 Billion |
| 2014 | 14.18% | 7.71% | 1.34x | 1.37x | Rp170.70 Billion |
| 2015 | 12.17% | 6.38% | 1.30x | 1.47x | Rp93.10 Billion |
| 2016 | 11.70% | 5.87% | 1.39x | 1.44x | Rp78.05 Billion |
| 2017 | 11.34% | 5.69% | 1.29x | 1.55x | Rp64.12 Billion |
| 2018 | 9.97% | 5.08% | 1.28x | 1.53x | Rp-1.66 Billion |
| 2019 | 10.10% | 5.04% | 1.31x | 1.53x | Rp5.61 Billion |
| 2020 | 13.01% | 7.18% | 1.20x | 1.50x | Rp182.18 Billion |
| 2021 | 12.61% | 7.33% | 1.16x | 1.48x | Rp170.73 Billion |
| 2022 | 13.88% | 8.17% | 1.08x | 1.57x | Rp280.11 Billion |
| 2023 | 15.30% | 8.97% | 1.16x | 1.47x | Rp407.64 Billion |
| 2024 | 16.66% | 10.60% | 1.09x | 1.44x | Rp578.75 Billion |
Industry Comparison
This section compares Tempo Scan Pacific Tbk's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $958,786,987,633
- Average return on equity (ROE) among peers: 20.45%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Tempo Scan Pacific Tbk (TSPC) | Rp9.44 Trillion | 33.02% | 0.35x | $70.32 Million |
| Darya-Varia Laboratoria Tbk (DVLA) | $1.20 Trillion | 16.72% | 0.40x | $8.73 Million |
| Indofarma Tbk (INAF) | $292.57 Billion | 37.70% | 0.84x | $4.64 Million |
| Merck Tbk (MERK) | $416.74 Billion | 25.87% | 0.37x | $11.43 Million |
| Phapros Tbk PT (PEHA) | $821.61 Billion | 12.42% | 1.55x | $4.70 Million |
| Pyridam Farma Tbk (PYFA) | $118.93 Billion | 7.10% | 0.57x | $76.03 Million |
| Sido Muncul PT (SIDO) | $2.90 Trillion | 22.87% | 0.15x | $192.60 Million |